Publicatie

Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive patients.

Jong, H.J. de, Vandebriel, R.J., Saldi, S.R., Dijk, L. van, Loveren, H. van, Cohen-Tervaert, J.W., Klungel, O.H. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive patients. Pharmacoepidemiology and Drug Safety: 2011, 20(suppl. 1) s68. Abstract. 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 14-17 Augustus 2011, Chicago.
Gegevensverzameling